Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,579.34
(
1.28%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
100.65
(
3.98%
)
Bitcoin
70,546.00
(
-0.50%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 165246

Wednesday, 08/14/2013 8:40:42 AM

Wednesday, August 14, 2013 8:40:42 AM

Post# of 257273

Tivicay’s competition is GILD’s Stribild/Elvitegravir and MRK’s Isentress

Think it's likely to take more share from Isentress (and of course will be used in patients with resistance to prior integrase inhibitors - Isentress and Elvitegravir).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today